Literature DB >> 19153507

Turner syndrome 2008.

Carolyn A Bondy1.   

Abstract

BACKGROUND: Fetuses with prenatal diagnoses of 45,X Turner syndrome (TS) and abnormal fetal ultrasounds have poor prognoses for survival, but with modern medical management, those that do survive to birth may have good clinical outcomes. Fetuses with incidental diagnoses of mosaicism for 45,X associated with normal ultrasounds have a high survival rate and may have no or only mild features of TS. CURRENT GUIDELINES: At present, appropriate treatment for girls with TS may include growth-promoting therapy and pubertal induction with the dual aims of optimizing adult height and facilitating psychosocial adjustment. Current recommendations advocate mimicking normal physiology as much as possible, with use of microdose estradiol to initiate puberty. Healthcare providers should play a role in helping girls psychosocially adapt to ovarian failure. We now recognize there is an unacceptably high rate of premature mortality in adults with TS, mainly because of complications from congenital heart disease. Cardiac magnetic resonance imaging is recommended to screen for individuals at high risk for serious complications. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19153507     DOI: 10.1159/000178039

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  9 in total

1.  Global survey of escape from X inactivation by RNA-sequencing in mouse.

Authors:  Fan Yang; Tomas Babak; Jay Shendure; Christine M Disteche
Journal:  Genome Res       Date:  2010-04-02       Impact factor: 9.043

Review 2.  Sex differences in obesity: X chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities.

Authors:  Karen Reue
Journal:  Physiol Behav       Date:  2017-03-08

Review 3.  The importance of having two X chromosomes.

Authors:  Arthur P Arnold; Karen Reue; Mansoureh Eghbali; Eric Vilain; Xuqi Chen; Negar Ghahramani; Yuichiro Itoh; Jingyuan Li; Jenny C Link; Tuck Ngun; Shayna M Williams-Burris
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-02-01       Impact factor: 6.237

Review 4.  Genetics of congenital heart disease: the glass half empty.

Authors:  Akl C Fahed; Bruce D Gelb; J G Seidman; Christine E Seidman
Journal:  Circ Res       Date:  2013-02-15       Impact factor: 17.367

5.  Female bias in Rhox6 and 9 regulation by the histone demethylase KDM6A.

Authors:  Joel B Berletch; Xinxian Deng; Di Kim Nguyen; Christine M Disteche
Journal:  PLoS Genet       Date:  2013-05-02       Impact factor: 5.917

Review 6.  Escape from X inactivation in mice and humans.

Authors:  Joel B Berletch; Fan Yang; Christine M Disteche
Journal:  Genome Biol       Date:  2010-06-24       Impact factor: 13.583

7.  CRISPR/Cas9-mediated targeted chromosome elimination.

Authors:  Erwei Zuo; Xiaona Huo; Xuan Yao; Xinde Hu; Yidi Sun; Jianhang Yin; Bingbing He; Xing Wang; Linyu Shi; Jie Ping; Yu Wei; Wenqin Ying; Wei Wei; Wenjia Liu; Cheng Tang; Yixue Li; Jiazhi Hu; Hui Yang
Journal:  Genome Biol       Date:  2017-11-24       Impact factor: 13.583

8.  Cytogenetic Study of Patients with Primary Amenorrhea in the Northeast of Iran.

Authors:  Narjes Soltani; Farzaneh Mirzaei; Hossein Ayatollahi
Journal:  Iran J Pathol       Date:  2020-10-26

Review 9.  Consanguinity and Congenital Heart Disease Susceptibility: Insights into Rare Genetic Variations in Saudi Arabia.

Authors:  Nour Albesher; Salam Massadeh; Sabah M Hassan; Manal Alaamery
Journal:  Genes (Basel)       Date:  2022-02-16       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.